Though the molecular mechanisms mediating numerical and functional alteration of CD34+/CD133+ HSPCs in diabetes are still largely obscure (reviewed in [61]), BM is emerging as the original core of HSPC dysfunction. Here, CD34 is linked to diabetes mellitus.